Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNNGet Free Report)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $21.82, but opened at $22.99. Anbio Biotechnology shares last traded at $21.41, with a volume of 3,453 shares trading hands.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, February 9th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has an average rating of “Hold”.

Get Our Latest Stock Report on Anbio Biotechnology

Anbio Biotechnology Price Performance

Anbio Biotechnology (NASDAQ:NNNNGet Free Report) last posted its quarterly earnings results on Tuesday, December 30th. The company reported $0.04 earnings per share (EPS) for the quarter. The company had revenue of $2.29 million during the quarter.

About Anbio Biotechnology

(Get Free Report)

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.

See Also

Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.